Tag Archives: act

Alexion, Biogen Among Leading Big-Cap Biotechs

Growth stocks are taking a hit now that the market is in a correction. Biotechs saw a recent sell-off over concerns that the sector was overheating, but biotechs and medical stocks are among leading big-cap stocks. IBD’s Big Cap Screen of the Day lists large stocks with strong earnings and price performance. Actavis (ACT), Alexion Pharmaceuticals (ALXN), Biogen (BIIB), Allergan (AGN) and Novo Nordisk (NVO) are featured on the screen. “If you look

Pfizer Loses Patent On Celebrex, Plans To Appeal

Big pharma Pfizer (PFE) briefly halted trading Wednesday afternoon to announce that a patent on best-selling arthritis drug Celebrex had been invalidated by a district court. When trading resumed, shares were down nearly 1% in the stock market today. Pfizer had sued five makers of generic drugs — Teva Pharmaceutical Industries (TEVA), Mylan (MYL), Watson Laboratories (now part of Actavis (ACT), Lupin Pharmaceuticals and Apotex — that were angling

Actavis Q4 Beats Street; Guidance Affirmed For Now

Drugmaker Actavis (ACT) beat analysts’ Q4 estimates on both the top and bottom lines Thursday, and affirmed its 2014 guidance pending the completion of its buyout of Forest Laboratories (FRX). The stock was up 3% in morning trading on the stock market today and touched an all-time high for the third straight day, above 218. The stock is extended after a 166.42 breakout in early December from a three-weeks tight pattern and ranks No. 8 on the